Why bacteria are not the main delivery vehicles for gene therapy:
* Immune response: Bacteria are recognized as foreign invaders by the human immune system. This triggers a strong inflammatory response, which can be harmful and could even lead to the rejection of the therapy.
* Safety concerns: Introducing live bacteria into the human body carries risks of infection and potential complications.
* Delivery limitations: Bacteria are not as efficient at targeting specific cells or tissues compared to other vectors like viruses.
How bacteria contribute to gene therapy:
* Production of viral vectors: Viruses, particularly adenoviruses and retroviruses, are the most common vectors used in gene therapy. Bacteria are employed to grow and manufacture these viruses in large quantities.
* Production of therapeutic proteins: Bacteria are highly efficient at producing proteins. This makes them ideal for manufacturing therapeutic proteins that are used in gene therapy, such as growth factors or enzymes.
* Research and development: Bacteria are valuable tools for studying gene function and developing new gene therapy strategies. They allow researchers to manipulate and analyze genes in a controlled environment.
In summary:
While bacteria themselves are not typically used as vectors in gene therapy due to safety concerns and limited targeting abilities, they play a vital role in the production of gene therapy components and in research and development.
